SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-20-005588
Filing Date
2020-04-27
Accepted
2020-04-27 16:15:02
Documents
3
Period of Report
2020-04-27
Effectiveness Date
2020-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2020def14a.htm DEF 14A 641556
2 a16030_corceptproxycardrev.jpg GRAPHIC 952750
3 a16030_corceptproxycardrev1.jpg GRAPHIC 250147
  Complete submission text file 0001628280-20-005588.txt   2299258
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50679 | Film No.: 20820122
SIC: 2834 Pharmaceutical Preparations